David Hughes, BSN, discusses how his institution uses a variety of criteria to target patients who might be eligible for clinical pathway inclusion.
The objective of this article is to review the strengths and limitations of commonly used methods for measuring adherence, describe the significance of a gold standard, and explore several candidates for this designation.
A Novel Case Management System to Address Patient-Identified Concerns in Hematology and Oncology Clinical Pathways
Researchers report on a novel patient-reported outcomes quality-of-life tool incorporated into a clinical pathway to see if patient well-being could be improved.
Associations Between Pre- and Post-Cancer Depression Diagnoses and End-of-Life Cancer Care Intensity
In a retrospective study, authors exaimed whether depression diagnoses were associated with end-of-life care intensity among elderly cancer decedents.
Authors present findings on the limited knowledge and misconceptions of health care providers regarding patient-centered medicine and patient-reported outcomes.
Dr Stepanski adds to the discussion on patient-reported outcomes in oncology with a counterpoint on the recent progress of these measures in trials and care settings.
Dr Mckenna looks at how patient-reported outcome measures have been used in oncology and how they can be better utilized to improve patient outcomes.
In Defense of Meaningful Use: The Potential of Electronic Health Records Systems to Support Value-Based Care
An enlarged historical perspective makes apparent the fundamental and positive transformation of health care initiated by the Meaningful Use program.
In this article, the author discusses the most prominent value frameworks that have been recently developed and compare each of their methods for defining value.
Brett Wilson, CEO and founder of Walking Miracles, reponds to viewpoints published in the May issue of JCP highlighting the problem of cancer drug shortages in pediatrics.